Armenia vs Singapore: HIV/AIDS deaths averted by antiretroviral therapy
Armenia
267.92 deaths
in 2024
Singapore
331.57 deaths
in 2023
Armenia rank
105th
Singapore rank
102nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Armenia
- Singapore
How they compare
Singapore currently reports 331.57 deaths against 267.92 deaths in Armenia, a difference of 63.65 deaths.
That makes Singapore's figure about 1.2 times Armenia's.
Across all 34 years both countries report, Singapore has been ahead every year.
Armenia ranks 105th and Singapore ranks 102nd of 157 countries.
Singapore has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Armenia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0.6975 deaths | 0.6975 deaths | Singapore |
| 2000s | 7.12 deaths | 53.47 deaths | 46.35 deaths | Singapore |
| 2010s | 94.52 deaths | 253.24 deaths | 158.72 deaths | Singapore |
| 2020s | 216.53 deaths | 336.06 deaths | 119.53 deaths | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Armenia or Singapore?
- Singapore, at 331.57 deaths against 267.92 deaths in Armenia as of 2023.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Armenia and Singapore?
- 63.65 deaths, with Singapore ahead.
- How many years of comparable data are there for Armenia and Singapore?
- 34 years are reported by both, from 1990 to 2023.
- How do Armenia and Singapore rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Armenia ranks 105th and Singapore ranks 102nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.